![Wei Kong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 305 M $ al 31/01/2026
Wei Kong is currently the General Manager & Director at Changchun BCHT Biotechnology Co. since 2004.
Prior to this, he obtained a doctorate degree from Jilin University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2024 | 104.448.497 ( 25,25 % ) | 305 M $ | 31/01/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CHANGCHUN BCHT BIOTECHNOLOGY CO. | Director Ejecutivo | 01/01/2004 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Jilin University
 Jilin University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Changchun BCHT Biotechnology Co.
 Changchun BCHT Biotechnology Co. BiotechnologyHealth Technology Engages in research and development, production and sales of human vaccines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
MarketScreener is also available in this country: United States.
Switch edition
